Athanase Innovation AB Statistics
Want to see SE:ATIN full AI Analyst Report?
Athanase Innovation AB (ATIN) Stock Statistics & Valuation Metrics
Total Valuation
Athanase Innovation AB has a market cap or net worth of SEK 289.46M. The enterprise value is SEK 64.38M.
- Market Cap
- SEK 289.46M
- Enterprise Value
- SEK 64.38M
Share Statistics
Athanase Innovation AB has 19,297,642 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 19,297,642
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Athanase Innovation AB’s return on equity (ROE) is -0.13 and return on invested capital (ROIC) is -19.04%.
- Return on Equity (ROE)
- -0.13
- Return on Assets (ROA)
- -0.12
- Return on Invested Capital (ROIC)
- -19.04%
- Return on Capital Employed (ROCE)
- -0.19
- Revenue Per Employee
- 1.37M
- Profits Per Employee
- -2.13M
- Employee Count
- 27
- Asset Turnover
- 0.08
- Inventory Turnover
- 17.97
Valuation Ratios
The current PE Ratio of Athanase Innovation AB is -5.32. Athanase Innovation AB’s PEG ratio is 0.26.
- PE Ratio
- -5.32
- PS Ratio
- 8.87
- PB Ratio
- 0.79
- Price to FCF
- -39.95
- Price to Operating Cash Flow
- -4.98
- PEG Ratio
- 0.26
Income Statement
In the last 12 months, Athanase Innovation AB had revenue of 36.86M and earned -57.62M in profits. Earnings per share was -2.99.
- Revenue
- 36.86M
- Gross Profit
- -95.53M
- Operating Income
- -81.41M
- Pretax Income
- -58.28M
- Net Income
- -57.62M
- EBITDA
- -67.29M
- Earnings Per Share (EPS)
- -2.99
Cash Flow
In the last 12 months, operating cash flow was -58.14M and capital expenditures 58.14M, giving a free cash flow of -7.25M billion.
- Operating Cash Flow
- -58.14M
- Free Cash Flow
- -7.25M
- Free Cash Flow per Share
- -0.38
Dividends & Yields
Athanase Innovation AB pays an annual dividend of SEK 289.50, resulting in a dividend yield of ―
- Dividend Per Share
- SEK 289.50
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.50%
- Earnings Yield
- -18.81%
Stock Price Statistics
- Beta
- 0.27
- 52-Week Price Change
- -10.71%
- 50-Day Moving Average
- 19.24
- 200-Day Moving Average
- 17.37
- Relative Strength Index (RSI)
- 0.19
- Average Volume (3m)
- 199
Important Dates
Athanase Innovation AB upcoming earnings date is Feb 19, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Feb 19, 2027
- Ex-Dividend Date
- Jan 11, 2021
Financial Position
Athanase Innovation AB as a current ratio of 5.11, with Debt / Equity ratio of 0.00%
- Current Ratio
- 5.11
- Quick Ratio
- 4.97
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 3.65
- Interest Coverage Ratio
- -75.87
Taxes
In the past 12 months, Athanase Innovation AB has paid 331.00K in taxes.
- Income Tax
- 331.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
Athanase Innovation AB EV to EBITDA ratio is 0.45, with an EV/FCF ratio of 4.43.
- EV to Sales
- -0.98
- EV to EBITDA
- 0.45
- EV to Free Cash Flow
- 4.43
- EV to Operating Cash Flow
- 0.55
Balance Sheet
Athanase Innovation AB has SEK 321.58M in cash and marketable securities with SEK 0.00 in debt, giving a net cash position of SEK 321.58M billion.
- Cash & Marketable Securities
- SEK 321.58M
- Total Debt
- SEK 0.00
- Net Cash
- SEK 321.58M
- Net Cash Per Share
- SEK 16.66
- Tangible Book Value Per Share
- SEK 18.95
Margins
Gross margin is -131.95%, with operating margin of -206.05%, and net profit margin of -166.87%.
- Gross Margin
- -131.95%
- Operating Margin
- -206.05%
- Pretax Margin
- -169.50%
- Net Profit Margin
- -166.87%
- EBITDA Margin
- -218.16%
- EBIT Margin
- -240.75%
Analyst Forecast
The average price target for Athanase Innovation AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -33.93%
- EPS Growth Forecast
- -9.82%
Scores
- Smart Score
- ―
- AI Score
- 46

